NCT00025259 Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease Status COMPLETED Phase PHASE3
NCT00025077 Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors Status COMPLETED Phase PHASE2
NCT00024440 Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia Status COMPLETED Phase PHASE3
NCT00024193 Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma Status UNKNOWN Phase PHASE2
NCT00023998 Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma Status COMPLETED Phase PHASE2
NCT00023959 Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer Status COMPLETED Phase PHASE1
NCT00023777 S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia Status COMPLETED Phase PHASE2
NCT00023738 Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma Status COMPLETED Phase PHASE1/PHASE2
NCT00022737 Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE3
NCT00022230 Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT00021333 Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer Status COMPLETED Phase PHASE2
NCT00020943 Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma Status COMPLETED Phase PHASE2
NCT00020410 Radiolabeled Monoclonal Antibody Followed by Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT00020371 BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy Status COMPLETED Phase PHASE1
NCT00020176 Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer Status COMPLETED Phase PHASE2
NCT00019864 Combination Chemotherapy Before and After Surgery in Treating Patients With Osteosarcoma Status TERMINATED Phase PHASE2
NCT00019474 Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer Status COMPLETED Phase PHASE2
NCT00017641 Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus Status UNKNOWN Phase PHASE1
NCT00017628 Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE1
NCT00017381 Monoclonal Antibody Therapy and Peripheral Stem Cell Transplant in Treating Patients With Non-Hodgkin's Lymphoma Status COMPLETED Phase EARLY_PHASE1